leadf
logo-loader
viewHeartseed

Heartseed developing heart failure treatment

Heartseed Inc CEO Keiichi Fukuda sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Tokyo-based biotechnology company is developing a treatment for heart failure, and recently raised $26M in Series B funding.

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Skinny Drinks Group new Managing Director Kavita Healy presents 'phenomenal...

Skinny Drinks Group new Management Director Kavita Healy joins Proactive London to talks about her background and ambitions for the company having joined the company at the end of June.  Sixty days into the job, Healy has already overseen moving into brand new headquarters which houses their...

5 hours ago

2 min read